Device Firms Need More Help Making Direct-To-Consumer “Brief Statements”
This article was originally published in The Gray Sheet
Executive Summary
Device manufacturers should be given the opportunity to have FDA review their direct-to-consumer ads for restricted devices before they go public, according to AdvaMed
You may also be interested in...
Device Firms Under Pressure To Add More Warnings To DTC Ads
Public pressure is increasing on device firms, especially orthopedic implant manufacturers, to include more detailed risk information about their products in direct-to-consumer broadcast advertisements
Device Firms Under Pressure To Add More Warnings To DTC Ads
Public pressure is increasing on device firms, especially orthopedic implant manufacturers, to include more detailed risk information about their products in direct-to-consumer broadcast advertisements
Device Firms Go Direct To Consumers Amid Physician Skepticism
Device firms are increasing investments in television advertising for their implantable products, but some physicians are skeptical that safety information about complex devices can be adequately conveyed in direct-to-consumer ads